More News
US Senate Finance Chair looking into pharma international tax abuse
Pharmaceutical industry tax practices involving the use of offshore subsidiaries to avoid paying US taxes are the target of an investigation by US Senate Finance Committee Chair Ron Wyden (D-Ore.), who requested information from Bristol Myers Squibb on January 18; this latest information request follows a similar letter sent to . . .
Finnish R&D study supports use of tax incentives to spur growth
Finland’s Ministry of Finance on January 13 announced the results from a research report reviewing the effectiveness of subsidies for research and development (R&D) activity, stating that the results support the use of R&D tax incentives as “proper policy” in Finland; however, while the report found that open-use R&D subsidies like tax incentives are . . .
US finalizes tax rules for transition from interbank offered rates
The US Internal Revenue Service released final regulations on December 30 that provide that certain changes to debt instruments, derivative contracts, and other contracts to change the reference rate due to the discontinuation of the London Interbank Offered Rate (LIBOR) and other interbank offered rates will not result in a tax . . .